Top 5 Board Review Apps for Primary Care Providers

September 9th 2025

Weekly Dose Podcast: Psoriasis Drug Success, Intranasal Insulin Insights, and New Data on Vaccines and GLP-1 Use

New data show the LP.8.1-adapted COVID-19 vaccine generates ≥4-fold antibody increases in older and high-risk adults, with no new safety concerns.

Salt Substitute Use Remains Rare Among US Adults With Hypertension, Two-Decade Survey Finds

This week’s podcast covers psoriasis trial results, intranasal insulin, COVID-19 booster safety, GLP-1 use in diabetes, and RSV vaccine uptake.

September 8th 2025

Weekly Dose Podcast: CRC Screening Uptake, GLP-1 Eligibility in Youth, Women’s Heart Health, and Ultraprocessed Food Risks

Analysis presented at AHA Hypertension 2025 showed fewer than 6% of US adults use salt substitutes, despite their potential to improve BP control.

August 28th 2025

High-Dose Influenza Vaccine Reduces Risk of Myocarditis and Pericarditis in Older Adults

This week’s podcast episode covers CRC screening, GLP-1 eligibility in youth, women’s heart health, FIT outreach, and ultraprocessed food risks.

Data Show Many US Adults Lack Awareness About HPV, Vaccine: Daily Dose

A secondary analysis of the DANFLU-2 trial found adults ≥65 receiving a high-dose flu vaccine had a 46% lower risk of myocarditis or pericarditis compared with standard-dose vaccination.

Phase 3 Data Confirm Strong Immune Response With Pfizer-BioNTech LP.8.1 COVID-19 Vaccine for 2025–2026 Season

Your daily dose of the clinical news you may have missed.

Related Content

September 9th 2025

Weekly Dose Podcast: Psoriasis Drug Success, Intranasal Insulin Insights, and New Data on Vaccines and GLP-1 Use

New data show the LP.8.1-adapted COVID-19 vaccine generates ≥4-fold antibody increases in older and high-risk adults, with no new safety concerns.

Salt Substitute Use Remains Rare Among US Adults With Hypertension, Two-Decade Survey Finds

This week’s podcast covers psoriasis trial results, intranasal insulin, COVID-19 booster safety, GLP-1 use in diabetes, and RSV vaccine uptake.

September 8th 2025

Weekly Dose Podcast: CRC Screening Uptake, GLP-1 Eligibility in Youth, Women’s Heart Health, and Ultraprocessed Food Risks

Analysis presented at AHA Hypertension 2025 showed fewer than 6% of US adults use salt substitutes, despite their potential to improve BP control.

August 28th 2025

High-Dose Influenza Vaccine Reduces Risk of Myocarditis and Pericarditis in Older Adults

This week’s podcast episode covers CRC screening, GLP-1 eligibility in youth, women’s heart health, FIT outreach, and ultraprocessed food risks.

Data Show Many US Adults Lack Awareness About HPV, Vaccine: Daily Dose

A secondary analysis of the DANFLU-2 trial found adults ≥65 receiving a high-dose flu vaccine had a 46% lower risk of myocarditis or pericarditis compared with standard-dose vaccination.